
Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432
Keywords: Tipifarnib; Farnesyltransferase inhibitor; Acute myeloid leukemia; Older; Untreated